Ulrich Laufs
Surgery · 2002–2020
A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Surgery — 207 citations into it
- Cancer Research — 48 citations into it
- Radiology, Nuclear Medicine and Imaging — 26 citations into it
Whom Ulrich Laufs trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Ulrich Laufs overall
Papers from Ulrich Laufs's perspective
Ordered by how strongly the researchers Ulrich Laufs trusts endorse each paper. Same corpus, a different order for every researcher.
- Statin safety: a systematic review. (American Journal of Cardiology)
- Rosuvastatin in older patients with systolic heart failure. (Current Atherosclerosis Reports)
- Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study (Cardiovascular Drugs and Therapy)
- Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. (Arteriosclerosis, Thrombosis and Vascular Biology)
- Interpretation of the evidence for the efficacy and safety of statin therapy. (The Lancet)
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. (The Lancet)
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemia (Nature Genetics)
- Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. (Journal of the American College of Cardiology)
- The evolving role of statins in the management of atherosclerosis. (Journal of the American College of Cardiology)
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus (New England Journal of Medicine)
Their papers
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel (2020) — 1,302 citations
- 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (2019) — 4,665 citations
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel (2017) — 3,303 citations
- Pleiotropic Effects of Statins on the Cardiovascular System (2017) — 1,071 citations
- Pleiotropic effects of statins. (2005) — 1,162 citations
- Intravenous Transfusion of Endothelial Progenitor Cells Reduces Neointima Formation After Vascular Injury (2003) — 743 citations
- Cellular Antioxidant Effects of Atorvastatin In Vitro and In Vivo (2002) — 624 citations